Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, Luisa M. Solis et al.|Cancer Cell|2021Cited by 930
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung CancerStephen G. Swisher, Martin Waugh, Jack A. Roth et al.|JNCI Journal of the National Cancer Institute|1999Cited by 497
Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II studyRobert I. Haddad, Marshall R. Posner, A. Dimitrios Colevas et al.|Oral Oncology|2003Cited by 262
HER2 Expression in Salivary Gland CarcinomasBonnie S. Glisson, Marshall R. Posner, A. Dimitrios Colevas et al.|Clinical Cancer Research|2004Cited by 202